MEDXT
MEDXT
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
MEDXT demonstrates extremely weak fundamentals across multiple key metrics, compounded by substantial data gaps. The project lacks active development, with no public code repositories, changelogs, or recent technical releases indicating ongoing work. Tokenomics present extreme centralization risks due to a total supply of 25 billion tokens with zero reported circulating supply, lack of documented vesting, and negligible market liquidity. Market traction is effectively nonexistent, characterized by near-zero daily trading volume and inconsistent naming on aggregators. Two sections—Community Support and Team and Governance—scored -1.0 due to severe data gaps and failed identity convergence across ambiguous online profiles. On the positive side, MEDXT underwent a third-party smart contract audit by Hashlock in September 2024, although the audit identified unaddressed single-administrator centralization risks and a circumventable 3% DEX tax mechanism. No qualifying red-flag events such as exploits or legal enforcement actions were identified, but the project exhibits high risk and lack of product traction.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About MEDXT (MEDXT)
MEDXT (also referenced as MediChainX) is an ERC-20 token deployed on the Ethereum blockchain, launched in 2024. The project maps to medxt.ai, which positions itself as a provider of blockchain-based cybersecurity and compliance solutions for sectors such as healthcare, insurance, and government systems. Within its proposed framework, MEDXT is documented as a utility token designed to cover service fees across its cybersecurity protocol.
The project demonstrates minimal technical and market activity. Development appears stalled, with no public code repositories, changelogs, SDK releases, or governance proposals available to verify ongoing engineering work. In terms of market presence, the token experiences extremely low liquidity with negligible daily trading volume, an unreported market capitalization, and naming inconsistencies across data aggregators, where it is also indexed under the name 'medichainx.'
Security and governance analyses highlight several operational risks. A smart contract audit conducted by Hashlock in September 2024 identified key concerns, including an unaddressed single-administrator role presenting centralization risk and a 3% decentralized exchange transaction fee mechanism that can be circumvented. Additionally, the token features a total supply of 25 billion tokens with zero reported circulating supply and no publicly documented vesting schedules, while the team behind the project remains anonymous with unresolved identity convergence across public profiles.